Literature DB >> 2288648

Danazol suppresses the production of interleukin-1 beta and tumor necrosis factor by human monocytes.

H Mori1, M Nakagawa, N Itoh, K Wada, T Tamaya.   

Abstract

The effects of estradiol (E2), progesterone (P), and danazol on the production of interleukin-1 beta (IL-1 beta) and tumor necrosis factor (TNF) by OK-432 (a streptococcal preparation)-stimulated monocytes were examined. E2 and P at physiologic concentrations enhanced IL-1 beta and TNF production by monocytes from donors with lower control levels (without steroids added) of IL-1 beta and TNF. However, E2 and P at physiologic concentrations did not affect IL-1 beta and TNF production by monocytes from donors with higher control levels of IL-1 beta and TNF. Danazol inhibited IL-1 beta and TNF production by monocytes in a dose-dependent manner from not only donors with lower control levels of IL-1 beta and TNF but also donors with higher control levels of IL-1 beta and TNF. Danazol at a concentration of 10(-6) M significantly suppressed IL-1 beta and TNF production in the presence of E2 and/or P at concentrations giving peak responses of IL-1 beta production. These findings suggest possible new mechanisms of action for danazol in the treatment of endometriosis and infertility associated with immune abnormalities.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2288648     DOI: 10.1111/j.1600-0897.1990.tb01037.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  10 in total

1.  LC-MS/MS detection of increased androstenedione levels in patients receiving danazol therapy.

Authors:  Verena Gounden; Diala El-Maouche; Brian R Stolze; Ranganath Muniyappa; Steven J Soldin
Journal:  Ther Drug Monit       Date:  2014-12       Impact factor: 3.681

2.  Gonadotropin treatment restores in vitro interleukin-1beta and tumour necrosis factor-alpha production by stimulated peripheral blood mononuclear cells from patients with idiopathic hypogonadotropic hypogonadism.

Authors:  U Musabak; E Bolu; M Ozata; C Oktenli; A Sengul; A Inal; Z Yesilova; G Kilciler; I C Ozdemir; I H Kocar
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

3.  Follicle-stimulating hormone, interleukin-1, and bone density in adult women.

Authors:  Joseph G Cannon; Miriam Cortez-Cooper; Eric Meaders; Judith Stallings; Sara Haddow; Barbara Kraj; Gloria Sloan; Anthony Mulloy
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-12-30       Impact factor: 3.619

4.  Inhibition of relaxin-induced pubic symphyseal "relaxation" in guinea pigs by glycosaminoglycan polysulfates and pentosan polysulfate.

Authors:  B G Steinetz; G Lust
Journal:  Agents Actions       Date:  1994-08

Review 5.  Human tumour necrosis factor: physiological and pathological roles in placenta and endometrium.

Authors:  S Haider; M Knöfler
Journal:  Placenta       Date:  2008-11-22       Impact factor: 3.481

6.  Development of hepatocellular carcinoma after long-term immunosuppressive therapy including danazol in a dog.

Authors:  Kosuke Kobayashi; Takako Shimokawa Miyama; Kazuhito Itamoto; Shunsuke Noguchi; Kenji Baba; Takuya Mizuno; Masaru Okuda
Journal:  J Vet Med Sci       Date:  2016-06-20       Impact factor: 1.267

7.  [Efficacy of stanozolol and danazol in the treatment of non-severe aplastic anemia and their effects on CD4(+)CD25(+)Foxp3(+) regulatory T cells].

Authors:  H M Li; Z B Long; T Wang; B Han
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2022-02-14

Review 8.  Potential involvement of the immune system in the development of endometriosis.

Authors:  Cleophas M Kyama; Sophie Debrock; Jason M Mwenda; Thomas M D'Hooghe
Journal:  Reprod Biol Endocrinol       Date:  2003-12-02       Impact factor: 5.211

9.  Effects of Danazol on Clinical Improvement of Patients with Human T-cell Lymphotropic Virus Type I Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP): A Placebo-Controlled Clinical Trial.

Authors:  Reza Boostani; Hamidreza Saber; Mohammadmahdi Etemadi
Journal:  Iran J Basic Med Sci       Date:  2013-03       Impact factor: 2.699

10.  Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure.

Authors:  Fernando M Reis; Larissa M Coutinho; Silvia Vannuccini; Frédéric Batteux; Charles Chapron; Felice Petraglia
Journal:  Hum Reprod Update       Date:  2020-06-18       Impact factor: 15.610

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.